NMG
ABBV icon

New Millennium Group’s AbbVie ABBV Stock Holding History

New Millennium Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$182K Buy
796
+418
+111% +$95.2K 0.08% 66
2025
Q3 		$87.5K Buy
378
+77
+26% +$15.7K 0.04% 85
2025
Q2 		$55.8K Sell
301
-8
-3% -$1.49K 0.03% 94
2025
Q1 		$64.7K Buy
309
+1
+0.3% +$194 0.04% 81
2024
Q4 		$54.8K Sell
308
-13
-4% -$2.39K 0.03% 90
2024
Q3 		$63.3K Buy
321
+2
+0.6% +$373 0.04% 82
2024
Q2 		$54.7K Buy
+319
New +$52.8K 0.04% 93
2024
Q1 		– Sell
-365
Closed -$56.5K – 68
2023
Q4 		$56.5K Sell
365
-18
-5% -$2.62K 0.05% 91
2023
Q3 		$57K Buy
383
+35
+10% +$5.14K 0.05% 73
2023
Q2 		$46.9K Sell
348
-9
-3% -$1.32K 0.04% 91
2023
Q1 		$56.9K Sell
357
-246
-41% -$37.6K 0.06% 90
2022
Q4 		$97.5K Buy
603
+9
+2% +$1.38K 0.1% 72
2022
Q3 		$79K Hold
594
– – 0.09% 76
2022
Q2 		$91K Buy
+594
New +$90.8K 0.09% 71

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

New Millennium Group's ABBV Position: Q4 2025 in Review

New Millennium Group increased its AbbVie (ABBV) stake by 111% in Q4 2025, buying an estimated $95.2K and bringing the position to 796 shares worth $182K. The position accounts for 0.08% of the portfolio, ranked #66.

New Millennium Group first reported a position in ABBV in Q2 2022 and has held it in 14 quarters since. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • New Millennium Group held 796 shares of AbbVie worth $182K as of Q4 2025.
  • New Millennium Group bought 418 AbbVie shares in Q4 2025, an estimated $95.2K.
  • AbbVie made up 0.08% of New Millennium Group's portfolio in Q4 2025, its #66 holding.
  • New Millennium Group first reported a position in AbbVie in Q2 2022 and has held it in 14 quarters since.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.